Skip to content

Intravenous Ibuprofen for Intraoperative and Postoperative Pain Control in Morbidly Obese Patients: A Randomized Controlled Trial

Intravenous Ibuprofen for Intraoperative and Postoperative Pain Control in Morbidly Obese Patients: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202604482430281
Enrollment
60
Registered
2026-04-28
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Standard care

Sponsors

Aya Mohamed
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients were eligible for inclusion if they were aged between 20 and 60 years old and classified as ASA physical status I or II. Patients had to be classified as morbidly obese with a BMI greater than 40 kg/m². A confirmed clinical diagnosis of obstructive sleep apnea was mandatory based on documented clinical symptoms.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had a known allergy or hypersensitivity to ibuprofen or other NSAIDs. Other reasons for exclusion were an estimated operative time exceeding 4 hours, a history of congestive heart failure, uncontrolled diabetes mellitus, a history of chronic pain or chronic opioid consumption (defined as use for more than one week in the past three months). Patients with hepatic or renal impairment, known bleeding diathesis, a history of intracranial hemorrhage, or active gastrointestinal tract problems (such as gastritis or gastric bleeding) were also excluded.

Design outcomes

Primary

MeasureTime frame
The intensity of postoperative pain, assessed using the VAS at the PACU and subsequently at 2, 6, 12, and 24 hours postoperatively.

Secondary

MeasureTime frame
Secondary outcomes included analgesic efficacy and safety. Efficacy was measured by the time to first rescue analgesia, defined as the time interval (in minutes) from the end of surgery until the patient first requested the rescue dose of nalbuphine. Patient satisfaction was also assessed using a 5-point Likert scale, where 5=excellent and 1=no pass.

Countries

Egypt

Contacts

Public ContactAhmed Soliman

Mansoura University

ahmedsolimann9090@gmail.com0020109101273

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Jun 29, 2026